logo

Loading..
Loading..
logo
  • About the company
    About the company
      • Company in brief
      • Company history
      • Strategy and IP
      • Organisation
      • Founders
      • The Board
      • Senior Management
  • About melflufen
    About melflufen
      • About melflufen (INN melphalan flufenamide)
      • Mechanism of action
      • About Multiple Myeloma
      • About our research
        • Selected bibliography (in order of publishing)
  • Our clinical studies
    Our clinical studies
      • Investigator-Initiated Trials
      • Summary
      • O-12-M1
      • HORIZON
      • OCEAN
      • ANCHOR
      • BRIDGE
  • Investor Relations
    Investor Relations
      • Investor Relations contact
      • The share
        • Share capital development
        • Dividend policy
        • Ownership structure
        • Analysts
      • Press releases
      • Presentations
      • Posters
        • O-12-M1 posters
        • HORIZON (OP-106) Posters
        • ANCHOR (OP-104) posters
        • Pre-clinical Data posters
      • Financial reports
      • Calendar
      • Prospectus
      • Share issue May 2020
      • Share issue June 2019
      • Share issue January 2019
      • Share issue March 2018
  • Media
    Media
      • Press releases
      • Subscribe
      • Image bank
      • Media contact
  • Corporate governance
    Corporate governance
      • Corporate Governance Reports
      • Governance structure
      • General meeting
        • Annual General Meeting 2020
        • General Meetings
      • Nomination committee
        • Nomination Committee 2020
        • Nomination Committees
      • The Board of Directors
        • Board of Directors
        • Work of the Board of Directors
        • Board committees
      • Senior Management
      • Remuneration
      • Auditors
      • Internal control
      • Articles of association
  • Career
  • Contact
    Contact
      • Office HQ
      • Office US
      • Investor Relations
      • Medical Affairs
      • Clinical Studies
      • Career
Media Image bank

Image bank

Select category
  • Logotype
  • Management
  • Ohter members of the staff
  • The Board
Marty J Duvall - Chief Executive Officer View Marty J Duvall
View Anders Martin-Löf
Eva Nordström - Vice President, Chief Operating Officer View Eva Nordström
Fredrik Lehmann - Head of Research and CMC View Fredrik Lehmann
View Jakob Lindberg
Karin Eklund Vanderpol - Head of Regulatory Affairs View Karin Eklund Vanderpol
Karolina Vilval - General Counsel View Karolina Vilval
Mohamed Ladha - General Manager, US Business Unit View Mohamed Ladha
Nicolaas Klaas Bakker - EVP and Chief Medical Officer View Nicolaas Klaas Bakker
View Paula Boultbee
Rolf Gulliksen - Head of Global Corporate Communications View Rolf Gulliksen
  • Media
    • Press releases
    • Subscribe
    • Image bank
    • Media contact
  • Oncopeptides AB (publ)
  • Registration number: 556596-6438
  • info@oncopeptides.com
  • About cookies
  • Personal Data

© 2020 Oncopeptides AB (publ). All rights reserved.

Welcome to Oncopeptides AB’s (publ) website. In order to optimize your use of our website we use cookies. A cookie is a text file stored on your computer. If you want more information about what a cookie is, what the purpose of the cookie is and how you can block or delete cookies, please read the our cookie guidelines “About cookies”. By continuing, you agree to our use of cookies.

Close